MP Biomedicals
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, MP Biomedicals sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
MP Biomedicals: 4 sponsored US clinical trials, none currently recruiting.
MP Biomedicals sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HTLV I Associated Myelopathies, with 1 trials.
Upper-quartile sponsor footprint
MP Biomedicals sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
NCT05584176
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
NCT05584189
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
NCT03226119
Dual Algorithm Post Market Clinical Study
NCT03146013
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
How the MP Biomedicals archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: HTLV I Associated Myelopathies (1 trial), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
MP Biomedicals: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
MP Biomedicals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this MP Biomedicals page
4 registered trials is a research-attention snapshot, not an endorsement of MP Biomedicals or any single study.
- None of MP Biomedicals's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- HTLV I Associated Myelopathies is the condition MP Biomedicals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HTLV I Associated Myelopathies trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. MP Biomedicals pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.